The BioProcessing Summit

August 12–14, 2026, Boston, MA, USA

Coriolis Pharma will participate in The Bioprocessing Summit 2026, a global industry event bringing together scientists, engineers, and biopharma experts to discuss innovation, digitalization, analytics, and process development for next generation biologics.

The conference provides a valuable platform to exchange insights on current challenges across biologics development, from early developability assessment to formulation, analytical strategies, and manufacturing readiness.

Dr. Andrea Arsiccio will contribute to the scientific program with the presentation:

“In silico Models to Speed Up and De Risk Biologics Developability and Formulation Development”

His talk will explore how structure prediction, bioinformatics, machine learning, and molecular dynamics can be combined within an automated platform to support candidate selection, lead characterization, and formulation development.

Our team looks forward to scientific exchange in Boston and to discussing how Coriolis Pharma applies science driven approaches to accelerate and de risk biologics development.